VDI Nachrichten, a weekly German newspaper with a focus on technology and science, featured Thermosome’s technology and product focus. While being applicable in various therapeutic areas, the article highlights Thermosome’s focus of its proprietary drug development, which lies on cancer patients with locally-advanced solid tumors. In these patients, Thermosome aims to either improve antitumor responses in neoadjuvant treatment concepts or to allow long-term application for unresectable tumors.
- On 15. September 2016